Skip to main content
Log in

Efficacy and safety of the combination therapy Pilogel®/β-blocker: Interim results

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

The interim results of a multicentered clinical trial with the combination therapy Pilogel®/topical β-blocker (twice daily) in patients with primary open angle glaucoma or ocular hypertension are discussed. Six patients were treated with Pilogel® and a topical β-blocker for one month. Four out of six patients responded well to the combination therapy. Most patients experienced some difficulty in applying the gel and their eyelids stuck together on awakening. In two patients a superficial punctate keratitis was observed. We found an average decrease in intra-ocular pressure (IOP) of 22.5% 22.5 hours after Pilogel® administration, but there was some tendency towards higher evening values compared to morning values. In view of the appearance of a corneal haze as described by Johnson et al. during long-term treatment, longer follow-up is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aldrete J, McDonald TO, DeSousa B. Comparative evaluation of pilocarpine gel and timolol in patients with glaucoma. Glaucoma 1983; 5: 236–41.

    Google Scholar 

  2. Crandall AS, Levy NA, Hoskins HD, Welch JR. Characterization of subtle corneal deposits. J. Toxicol Cutan Ocular Toxicol 1984; 3: 263–9.

    Google Scholar 

  3. Goldberg I, Ashburn FS, Jr, Kass MA, Becker B. Efficacy and patient acceptance of pilocarpine gel. Am J Ophthalmol 1979; 88: 843–6.

    Google Scholar 

  4. Johnson DH, Epstein DL, Alien RC, Boys-Smith J, Cambell D, Rosenquist R, Van Buskirk EM. A one year multicenter clinical trial of pilocarpine gel. Am J Ophthalmol 1984; 79: 723–9.

    Google Scholar 

  5. Johnson DH, Kenyon KR, Epstein DL, Van Buskirk EM. Corneal changes during pilocarpine gel therapy. Am J Ophthalmol 1986; 101: 13–5.

    Google Scholar 

  6. Krause K, Küchle HJ, Baumgart M. Vergleichende Untersuchungen über Pilocarpin-Gel und Pilocarpin-Augentropfen. Klin Mbl Augenheilk 1985; 187: 178–83.

    Google Scholar 

  7. Krieglstain GK. Duration of effect of pilocarpine gel. Arch Ophthalmol 1982; 100: 1270–1.

    Google Scholar 

  8. Mandell AI, Bruce LA, Khalifa MA. Reduced cyclic myopia with pilocarpine gel. Ann Ophthalmol 1988; 20: 133–5.

    Google Scholar 

  9. March WF, Stewart RH, Mandell AI. Duration of effect of pilocarpine gel. Arch Ophthalmol 1982; 100: 1270–1.

    Google Scholar 

  10. Norell SE. Monitoring compliance with pilocarpine therapy. Am J Ophthalmol 1981; 92: 727–31.

    Google Scholar 

  11. Norell SE. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br J Ophthalmol 1980; 64: 137–41.

    Google Scholar 

  12. Schneider RJ, Schneider J. A clinical trial of pilocarpine gel in patients with refractory glaucoma. Glaucoma 1985; 7: 1778–81.

    Google Scholar 

  13. Stewart RH, Kimbrough RL, Smith JP. Long-acting pilocarpine gel: A dose-response in ocular hypertensive subjects. Glaucoma 1984; 6: 182–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maas, S., Ros, F.E., de Heer, L. et al. Efficacy and safety of the combination therapy Pilogel®/β-blocker: Interim results. Doc Ophthalmol 72, 391–398 (1989). https://doi.org/10.1007/BF00153508

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00153508

Key words

Navigation